Nevertheless, the critical determinant for ciprofloxacin tolerance among genetically distinct persisters is cellular ATP ...
Esperion Therapeutics Inc. has described ATP citrate lyase (ACLY) inhibitors reported to be useful for the treatment of cancer, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...
Atopia Therapeutics SA has reported new preclinical in vivo efficacy data supporting the potential of ATP-R13 as a novel oral treatment for atopic dermatitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results